Sign In
Buy FLXN
$25.10
-0.0069 (-0.0275%)
At Close: Jun 22, 2026
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
New York State Common Retirement Fund Sells 6,200 Shares of Flexion Therapeutics Inc (NASDAQ:FLXN)
11:54am, Saturday, 07'th Mar 2020
New York State Common Retirement Fund reduced its stake in Flexion Therapeutics Inc (NASDAQ:FLXN) by 17.8% during the 4th quarter, according to the company in its most recent 13F filing with the Secur
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09:30pm, Friday, 06'th Mar 2020
The Compensation Committee of the Board of Directors approved the grants with an effective date of March 2, 2020. The stock options and restricted stock units were granted as inducements material to
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09:30pm, Friday, 06'th Mar 2020
BURLINGTON, Mass., March 06, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to three new...
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 56'5(c)(4)
12:00am, Friday, 06'th Mar 2020Will Flexion Therapeutics (FLXN) Report Negative Earnings Next Week? What You Should Know
05:30pm, Thursday, 05'th Mar 2020
Flexion Therapeutics (FLXN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Flexion Therapeutics (FLXN) Report Negative Earnings Next Week? What You Should Know
05:30pm, Thursday, 05'th Mar 2020
Flexion Therapeutics (FLXN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Flexion Therapeutics (FLXN) to Release Quarterly Earnings on Thursday
03:08pm, Thursday, 05'th Mar 2020
Flexion Therapeutics (NASDAQ:FLXN) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, March 12th. Analysts expect the company to announce earnings of ($1.00) p
Will Flexion Therapeutics (FLXN) Report Negative Earnings Next Week? What You Should Know
12:00am, Thursday, 05'th Mar 2020Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2019 Financial Results on March 12, 2020
09:30pm, Wednesday, 04'th Mar 2020
BURLINGTON, Mass., March 04, 2020 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its fourth-quarter and full-year 2019 financial results after.
Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2019 Financial Results on March 12, 2020
09:30pm, Wednesday, 04'th Mar 2020
BURLINGTON, Mass., March 04, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its fourth-quarter and...
Flexion Therapeutics to Report Fourth-Quarter and Full-Year —…–9 Financial Results on ...
12:00am, Wednesday, 04'th Mar 20203 High-Risk, High-Reward Stocks That Have Massive Upside Potential
12:25pm, Saturday, 29'th Feb 2020
If you can handle the uncertainty, these small-cap stocks can make you very wealthy.
Essex Investment Management Co. LLC Invests $414,000 in Flexion Therapeutics Inc (NASDAQ:FLXN)
12:24pm, Saturday, 29'th Feb 2020
Essex Investment Management Co. LLC purchased a new position in Flexion Therapeutics Inc (NASDAQ:FLXN) during the fourth quarter, according to its most recent Form 13F filing with the Securities and E
